The present study aimed to assess the function and mechanism of TNFR2 in PDAC and the potential of a combination of TNFR2 blockade and PD-L1 blockage to treat pancreatic cancer. The gene discussed is TNFRSF1B; the disease is pancreatic neoplasm.